Liu, S., Liang, Z., Zhu, L., Zheng, Y., Yu, H., Ye, S., Liang, T., Huang, L., Ouyang, J., Cao, Y., Ye, L., Ye, L.

Background
Intrahepatic cholangiocarcinoma (ICC) offers limited opportunities for surgical treatment, and advanced-stage patients exhibit poor responses to immunotherapy. Therefore, the exploration of new therapeutic strategies is of paramount importa…